Lv3
218 积分 2024-08-25 加入
Concanavalin‐A‐Induced Acute Liver Injury in Mice
12天前
已完结
Ebselen Protects Mice Against T Cell-Dependent, TNF-Mediated Apoptotic Liver Injury
12天前
已关闭
JAK Inhibition in STAT1 Gain-of-Function–Mediated Treatment-Resistant Autoimmune Hepatitis
18天前
已完结
Profiling of mouse and human liver diseases identifies targets for therapeutic treatment of autoimmune hepatitis
18天前
已完结
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
21天前
已完结
Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
21天前
已完结
Design and Baseline Characteristics of the STRIDE Trial: evaluating Semaglutide in People with Symptomatic Peripheral Artery Disease and Type 2 Diabetes
21天前
已完结
784-P: Once-Weekly Semaglutide in Patients with Peripheral Arterial Disease and Type 2 Diabetes—Comorbidities and Concomitant Medications from the STRIDE Trial
21天前
已关闭
Effects of semaglutide on functional capacity in patients with type 2 diabetes and peripheral arterial disease: rationale and design of the STRIDE trial
21天前
已完结
EFFECTS OF 1 MG ONCE-WEEKLY SEMAGLUTIDE ON FUNCTIONAL CAPACITY IN PATIENTS WITH TYPE 2 DIABETES AND PERIPHERAL ARTERIAL DISEASE: TRIAL DESIGN AND BASELINE CHARACTERISTICS FROM STRIDE A 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL
21天前
已完结
皖公网安备34019202002308
